Skip to main content

Advertisement

Log in

Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Studies on the effect of exogenous subclinical thyrotoxicosis on bone mineral density (BMD) in male patients treated with suppressive doses of levothyroxine for differentiated thyroid carcinoma (DTC) are not conclusive. In order to evaluate BMD (in femoral neck, lumbar spine, and distal radius) and bone fractures in men under long-term suppressive treatment with levothyroxine for DTC, we conducted a cross-sectional, retrospective study in 33 Caucasian men (mean ± SD age: 56 ± 14 years) under treatment for DTC. The control group comprised 33 healthy age- and body mass index-matched male volunteers. BMD was assessed by dual-energy X-ray absorptiometry (DXA). Bone turnover biomarkers (calcium, phosphate, alkaline phosphatase, PTH, vitamin D, urinary calcium, and N-Telopeptide/creatinine index) and testosterone were determined. Previous bone fractures were evaluated with a questionnaire and X-ray images of thoracic and lumbar vertebrae. Patients were treated for a mean duration of 15 ± 5 years. No differences were found between patients and controls in bone turnover biomarkers or areal BMD, T-scores or Z-scores in all sites evaluated. No earlier fractures or pain episodes were registered in either group and the incidence of asymptomatic vertebral fractures did not differ significantly between patient (18.8%) and control groups (16.7%), (P = 0.9). In conclusion, long-term suppressive treatment with levothyroxine in men with DTC does not appear to exert deleterious effects on bone mineral density or increase the prevalence of fracture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, E.L. Mandel Mazzaferri, R. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Thyroid 19(11), 1167–1214 (2009)

    Article  PubMed  Google Scholar 

  2. F. Pacini, M. Schlumberger, H. Dralle, R. Elisei, J.W. Smit, W. Wiersinga, Eur. J. Endocrinol. 154, 787–803 (2006)

    Article  CAS  PubMed  Google Scholar 

  3. D.S. Ross, Thyroid 4, 319–326 (1994)

    Article  CAS  PubMed  Google Scholar 

  4. N.F. Col, M.I. Surks, G.H. Daniels, JAMA 291, 239–243 (2004)

    Article  CAS  PubMed  Google Scholar 

  5. E. Murphy, G.R. Williams, Clin. Endocrinol. (Oxf) 61, 285–298 (2004)

    Article  CAS  Google Scholar 

  6. T. Diamon, L. Nery, I. Hales, J. Clin. Endocrinol. Metab. 72, 1184–1188 (1991)

    Article  Google Scholar 

  7. J.A. Franklyn, J. Betteridge, J. Daykin, R. Holder, G.D. Oates, J.V. Parle, J. Lilley, D.A. Heath, M.C. Sheppard, Lancet 340, 9–13 (1992)

    Article  CAS  PubMed  Google Scholar 

  8. S. Giannini, M. Nobile, L. Sartori, P. Binotto, M. Ciuffreda, G. Gemo, M.R. Pelizzo, A. D’Angelo, G. Crepaldi, Clin. Sci. 87, 593–597 (1994)

    CAS  PubMed  Google Scholar 

  9. C. Marcocci, F. Golia, G. Bruno-Bossio, E. Vignali, A. Pinchera, J. Clin. Endocrinol. Metab. 78, 818–823 (1994)

    Article  CAS  PubMed  Google Scholar 

  10. C.G. Muller, T.A. Bayley, J.E. Harrison, R. Tsang, Thyroid 5, 81–87 (1995)

    Article  CAS  PubMed  Google Scholar 

  11. G. Görres, A. Kaim, A. Otte, M. Götze, J. Muller-Brand, Eur. J. Nucl. Med. 23, 690–692 (1996)

    Article  PubMed  Google Scholar 

  12. E. Jódar, G. Martinez-Diaz-Guerra, S. Azriel, F. Hawkins, Calcif. Tissue Int. 69, 84–87 (2001)

    Article  PubMed  Google Scholar 

  13. A.C. Heijckmann, M.S. Huijberts, P. Geusens, J. de Vries, P.P. Menheere, B.H. Wolffenbuttel, Eur. J. Endocrinol. 153, 23–29 (2005)

    Article  CAS  PubMed  Google Scholar 

  14. J.L. Reverter, S. Holgado, N. Alonso, I. Salinas, M.L. Granada, A. Sanmartı, Endocr. Relat. Cancer 12, 973–981 (2005)

    Article  CAS  PubMed  Google Scholar 

  15. M. Eftekhari, A. Asadollahi, D. Beiki, S. Izadyar, A. Gholamrezanezhad, M. Assadi, A. Fard-Esfahani, B. Fallahi, A. Takavar, M. Saghari, Hell. J. Nucl. Med. 11, 160–163 (2008)

    PubMed  Google Scholar 

  16. F. Hawkins, D. Rigopoulou, K. Papapietro, M.B. Lopez, Calcif. Tissue Int. 54, 16–19 (1994)

    Article  CAS  PubMed  Google Scholar 

  17. C.Y. Guo, A.P. Weetman, R. Eastell, Clin. Endocrinol. (Oxf) 46, 301–307 (1997)

    Article  CAS  Google Scholar 

  18. A.W. Kung, T. Lorentz, S.C. Tam, Clin. Endocrinol. (Oxf) 39, 535–540 (1993)

    Article  CAS  Google Scholar 

  19. A.W. Kung, S.S. Yeung, J. Clin. Endocrinol. Metab. 81, 1232–1236 (1996)

    Article  CAS  PubMed  Google Scholar 

  20. C. Marcocci, F. Golia, E. Vignali, A. Pinchera, J. Bone Miner. Res. 12, 72–77 (1997)

    Article  CAS  PubMed  Google Scholar 

  21. J.J. Stĕpán, Z. Límanová, Bone Miner. 17, 377–388 (1992)

    Article  PubMed  Google Scholar 

  22. C.M. Florkowski, B.E. Brownlie, J.R. Elliot, E.M. Ayling, J.G. Turner, NZ. Med. J. 106, 443–444 (1993)

    CAS  Google Scholar 

  23. J. Toivonen, R. Tähtelä, K. Laitinen, J. Risteli, M.J. Välimäki, Eur. J. Endocrinol. 138, 667–673 (1998)

    Article  CAS  PubMed  Google Scholar 

  24. K.A. Heemstra, N.A. Hamdy, J.A. Romijn, J.W. Smit, Thyroid 16, 583–591 (2006)

    Article  CAS  PubMed  Google Scholar 

  25. J.A. Kanis, L.J. Melton III, C. Christiansen, C.C. Johnston, N. Khaltaev, J. Bone Miner. Res. 9, 1137–1141 (1994)

    Article  CAS  PubMed  Google Scholar 

  26. H.K. Genant, J. Li, C.Y. Wu, J.A. Shepherd, J. Clin. Densitom. 3, 281–290 (2000)

    Article  CAS  PubMed  Google Scholar 

  27. P.R. Ebeling, N. Eng. J. Med. 358, 1474–1482 (2008)

    Article  CAS  Google Scholar 

  28. L. Gennari, J.P. Bilezikian, Endocrinol. Metab. Clin. North Am. 36, 399–419 (2007)

    Article  CAS  PubMed  Google Scholar 

  29. S.R. Cummings, P.M. Cawthon, K.E. Ensrud, J.A. Cauley, H.A. Fink, E.S. Orwoll, J. Bone Miner. Res. 21, 1550–1556 (2006)

    Article  PubMed  Google Scholar 

  30. I. Karner, Z. Hrgović, S. Sijanović, D. Buković, A. Klobucar, K.H. Usadel, W.J. Fassbender, Eur. J. Med. Res. 10, 480–488 (2005)

    CAS  PubMed  Google Scholar 

  31. R.W. Flynn, S.R. Bonellie, R.T. Jung, T.M. MacDonald, A.D. Morris, G.P. Leese, J. Clin. Endocrinol. Metab. 95(1), 186–193 (2010)

    Article  CAS  PubMed  Google Scholar 

  32. A. Svare, T.I. Nilsen, T. Bjøro, S. Forsmo, B. Schei, A. Langhammer, Eur. J. Endocrinol. 161(5), 779–786 (2009)

    Article  CAS  PubMed  Google Scholar 

  33. S.J. Gallacher, A.P. Gallagher, C. McQuillian, P.J. Mitchell, T. Dixon, Osteoporos. Int. 18, 185–192 (2007)

    Article  CAS  PubMed  Google Scholar 

  34. M. Garton, I. Reid, N. Loveridge, S. Robins, L. Murchison, G. Beckett, D. Reid, Clin. Endocrinol. 41, 747–755 (1995)

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Mr David Duatis for his collaboration in the DXA procedures and Ms Christine O’Hara for her valuable contribution to the preparation of the manuscript.

Conflict of interest or disclosures

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jordi L. Reverter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reverter, J.L., Colomé, E., Holgado, S. et al. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. Endocr 37, 467–472 (2010). https://doi.org/10.1007/s12020-010-9339-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-010-9339-z

Keywords

Navigation